Business Segments Roche Holding AG London S.E.

Stocks

Market Closed - London S.E. 11:20:00 2026-10-02 EDT			5-day change	1st Jan Change
323.90 ^CHF	0.00%		0.00%	-1.29%

09-13	Roche Outlines Positive Phase 3 Trial Data for Small-cell Lung Cancer Treatment in China	MT
09-11	Scholar Rock gets first FDA nod for rare muscle-wasting disease (September 11)	RE

Breakdown by Business Segment (CHF)

Fiscal Period: December	2021	2022	2023	2024	2025
Pharmaceutical Products
Pharmaceuticals - Roche Pharmaceuticals	45.71B	46.35B	44.43B	46.34B	48.07B
Total Assets	44.86B	43.04B	46.08B	45.52B	48.3B
CAPEX	-2.79B	-2.3B	-3.12B	-1.31B	-1.21B
D&A	2.66B	2.14B	1.82B	1.72B	1.64B
Operating Income	12.6B	11.32B	13.87B	18.69B	20.3B
	-	-	-	-	4.06B
Pharmaceuticals - Chugai	8.36B	9.27B	7.2B	6.88B	7.02B
Total Assets	7.89B	8.89B	6.59B	6.38B	6.66B
CAPEX	-727M	-532M	-490M	-307M	-352M
D&A	249M	221M	196M	177M	175M
Operating Income	3.52B	3.99B	2.92B	3.28B	3.35B
EBITDA	19.89B	20.7B	21.43B	23.36B	24.8B
	-	-	-	-	1.58B
Medical Testing, Analyzing, and Diagnostic Equipment
Diagnostics	17.86B	17.82B	14.16B	14.46B	13.96B
Total Assets	21.46B	21.59B	20.48B	22.55B	21.63B
CAPEX	-1.78B	-1.76B	-1.98B	-1.81B	-2.01B
EBITDA	5.31B	4.8B	3.88B	3.7B	3.34B
D&A	1.46B	1.42B	1.37B	1.45B	1.5B
Operating Income	3.32B	3.32B	2.17B	2.4B	2B
	-	-	-	-	59M
Elimination	-6.08B	-7.02B	-5.35B	-5.29B	-5.7B
Total Assets	-4.08B	-4.63B	-3.03B	-2.98B	-3.74B
Operating Income	-596M	-497M	349M	38M	-202M
Total Assets	-	-	-	-	-
Total Assets	6.85B	4.99B	5.38B	6.98B	5.58B
Total Assets	6.18B	4.78B	5.13B	10.34B	9.89B
Operating Income	-694M	-662M	-3.91B	-3.59B	-3.6B
D&A	70M	69M	77M	72M	67M
EBITDA	-506M	-486M	-3.34B	-3.52B	-3.53B
CAPEX	-103M	-92M	-88M	-69M	-45M
Total Assets	420M	445M	555M	631M	668M

Geographical breakdown of sales (CHF)

Fiscal Period: December	2021	2022	2023	2024	2025
United States	28.06B	29.31B	28.35B	30.17B	30.72B
Total Assets	25.54B	23.56B	26.41B	27.33B	27.58B
CAPEX	-925M	-881M	-1.28B	-1.1B	-992M
	-	-	-	-	3.12B
Rest of Europe	11.38B	10.33B	9.7B	10.29B	10.86B
Total Assets	2.07B	1.85B	1.67B	2.01B	2.08B
CAPEX	-344M	-278M	-309M	-319M	-458M
	-	-	-	-	3.12B
China	-	-	-	-	4.82B
Total Assets	-	-	-	-	730M
CAPEX	-	-	-	-	-129M
Rest of Asia	9.76B	9.85B	8.89B	9.08B	3.78B
Total Assets	1.66B	1.53B	1.41B	1.48B	725M
CAPEX	-293M	-299M	-323M	-312M	-283M
	-	-	-	-	3.24B
Latin America	2.75B	2.87B	2.97B	3.25B	3.24B
Total Assets	333M	368M	418M	457M	462M
CAPEX	-116M	-138M	-192M	-176M	-149M
	-	-	-	-	1.36B
Germany	4.32B	3.32B	2.89B	2.94B	3.12B
Total Assets	5.36B	5.32B	5.26B	5.49B	5.61B
CAPEX	-635M	-668M	-612M	-612M	-666M
	-	-	-	-	4.82B
Japan	5.07B	6.45B	4.46B	3.29B	3.12B
Total Assets	3.06B	2.93B	2.7B	2.72B	2.68B
CAPEX	-609M	-456M	-448M	-315M	-364M
	-	-	-	-	3.78B
Africa, Australia and Oceania	1.48B	1.52B	1.21B	1.25B	1.36B
Total Assets	145M	138M	131M	151M	149M
CAPEX	-45M	-40M	-44M	-56M	-42M
	-	-	-	-	982M
Switzerland	2.12B	1.67B	1.12B	1.23B	1.34B
Total Assets	9.11B	8.98B	9.12B	9.08B	9.54B
CAPEX	-857M	-639M	-561M	-600M	-524M
	-	-	-	-	10.86B
Rest of North America	916M	1.1B	838M	889M	982M
Total Assets	58M	51M	41M	198M	190M
CAPEX	-2M	-3M	-5M	-6M	-12M
	-	-	-	-	30.72B
	-	-	-	-	1.34B